Connect with us

Business

Telix (ASX:TLX) share price sinks 6% on FDA update

Published

on

ADVERTISEMENT

Image source: Getty Images

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has plummeted today after the company announced news of its prostate cancer imaging investigational product, Illuccix.

Illuccix is currently in the midst of the US Food and Drug Administration’s…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending